OKLO isn't just an energy company

Industry Discussions Nuclear Power
1

Energy production is merely one of the several revenue streams OKLO has lined up

1 Like
2

At the Oklo website, they have a page describing their radioisotope production capabilities.

https://oklo.com/isotopes/default.aspx

The website also has a link to a pdf with more information. The pdf says the market for these isotopes was at $10.6 billion in 2025, and is projected to increase to $22.9 billion by 2035. That is, if there are enough reactors dedicated to produce the materials, which, by definition, can’t be stored very long.

_ Pete

2 Likes
3

University of Missouri also has an experimental reactor used to produce medical isotopes. I think it is in the process of being expanded.

Copilot says–

University of Missouri Medical Isotopes Program

The University of Missouri Research Reactor (MURR) is a major U.S. producer of critical medical radioisotopes used in cancer diagnosis and treatment, as well as in research and industrial applications MU Research Reactor**+1**.

Key Medical Isotopes Produced

MURR produces a range of radioisotopes, including:

  • Molybdenum‑99 (Mo‑99) – parent isotope for technetium‑99m, the most widely used medical isotope for imaging.

  • Iodine‑133 (I‑131) – used in thyroid cancer diagnosis and treatment.

  • Lutetium‑177 (Lu‑177) – used in targeted radionuclide therapy for certain cancers Research, Innovation & Impact.

These isotopes are essential because they cannot be stockpiled due to their short half‑lives; if not produced in time, treatments cannot be delivered Research, Innovation & Impact.

Role in Global Supply

MURR is the sole U.S. producer of Mo‑99, I‑131, and Lu‑177 Research, Innovation & Impact. It also supplies other isotopes through the National Isotope Development Center (NIDC), which coordinates U.S. Department of Energy isotope production, sales, and distribution MU Research Reactor.

In 2026, MURR increased production to help meet global demand after a European reactor shutdown disrupted supply chains Research, Innovation & Impact.

New Radioisotope Science Center (RSC)

In May 2026, MURR broke ground on the Radioisotope Science Center (RSC) at Discovery Ridge in Columbia, MO NIDC**+1**.

  • Funding: $20M from the U.S. Department of Energy’s Office of Isotope R&D and Production, matched by $20M from the State of Missouri NIDC**+1**.

  • Capacity: ~31,250 sq. ft., expected completion in 2028.

  • Purpose:

    • Expand U.S. production capacity for strategic isotopes.

    • Serve as a national hub for workforce development in nuclear science and radiochemistry.

    • Support translational research for clinical applications, national security, and industrial uses.

    • Accelerate discovery of new isotopes and improve production techniques NIDC**+1**.

The RSC will leverage MURR’s reactor infrastructure and expertise to produce, process, and distribute isotopes, and will train the next generation of scientists and engineers in the field NIDC.

Access and Ordering

MURR offers an MOOS (MURR Online Ordering System) for customers to request isotopes and radiochemicals MU Research Reactor. This system ensures timely delivery tailored to customer needs.

In summary: The University of Missouri’s MURR is a cornerstone of the U.S. medical isotope supply chain, producing life‑saving isotopes for cancer care, and is expanding its capabilities through the new Radioisotope Science Center to ensure a secure, domestic supply for decades to come.

1 Like